Skip to content

Evaluation of Eye Surface Health in Patients with Thyroid Eye Disease

PREVALENCE AND CLINICAL PROFILE OF OCULAR SURFACE DYSFUNCTION IN THYROID EYE DISEASE: A CROSS-SECTIONAL PERSPECTIVE - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/111965
Enrollment
60
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H052- Exophthalmic conditions

Interventions

Intervention1: Nil: Nil Control Intervention1: NIL: NIL

Sponsors

Sarojini Naidu Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 years or older. 2. Patients with clinically diagnosed Thyroid Eye Disease (TED). 3. Willing and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Presence of significant ocular surface disorders unrelated to TED that may independently influence ocular surface status, such as Stevens Johnson syndrome, ocular cicatricial pemphigoid, severe chemical injury, or limbal stem cell deficiency, 2.History of ocular surgery or significant ocular trauma within the previous 6 months.

Design outcomes

Primary

MeasureTime frame
To determine the prevalence of ocular surface dysfunction among patients with Thyroid Eye Disease and to describe the clinical profile of this dysfunction in these patientsTimepoint: Single point assessment at base line (the time of enrolment)

Secondary

MeasureTime frame
To assess the severity of ocular surface dysfunction using standardized diagnostic tools recommended by The Tear Film& Ocular Society (TFOS) Dry Eye Workshop(DEWS)III such as Schirmer s test, Tear Break-Up Time (TBUT), corneal fluorescein staining, conjunctival Lissamine Green staining & the Ocular Surface Disease Index (OSDI) questionnaire etc.Timepoint: Single point assessment at base line;To evaluate the association between ocular surface dysfunction & the clinical activity as well as severity of Thyroid Eye Disease using parameters such as Clinical Activity Score (CAS), degree of proptosis, & eyelid retractionTimepoint: Single point assessment at baseline;To identify clinical & demographic factors associated with ocular surface dysfunction in patients with Thyroid Eye Disease, including duration of disease, smoking status, & thyroid status. Timepoint: Single point assessment at baseline

Countries

India

Contacts

Public ContactShefali Mazumdar

Sarojini Naidu Medical College Agra

kartikdhaker2197@gmail.com7297874073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026